209 related articles for article (PubMed ID: 30293074)
1. Health-Related Quality of Life in Patients with Small Intestine Neuroendocrine Tumors.
Karppinen N; Lindén R; Sintonen H; Tarkkanen M; Roine R; Heiskanen I; Matikainen N; Schalin-Jäntti C
Neuroendocrinology; 2018; 107(4):366-374. PubMed ID: 30293074
[TBL] [Abstract][Full Text] [Related]
2. Quality of Life in Patients with Metastatic Gastroenteropancreatic Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy: Information from a Monitoring Program in Clinical Routine.
Martini C; Buxbaum S; Rodrigues M; Nilica B; Scarpa L; Holzner B; Virgolini I; Gamper EM
J Nucl Med; 2018 Oct; 59(10):1566-1573. PubMed ID: 30042164
[TBL] [Abstract][Full Text] [Related]
3. Neuroendocrine tumours of the small bowel: interpretation of raised circulating chromogranin A, urinary 5 hydroxy indole acetic acid and circulating neurokinin A.
Ardill JE; Armstrong L; Smye M; Doherty R; McCance DR; Johnston BT
QJM; 2016 Feb; 109(2):111-5. PubMed ID: 25979268
[TBL] [Abstract][Full Text] [Related]
4. Impaired breathing, sleeping, vitality, and depression, and negative impact of L-T4 treatment characterize health-related quality of life in older people with stable CVD.
Ojala AK; Sintonen H; Roine RP; Strandberg TE; Schalin-Jäntti C
Aging Clin Exp Res; 2020 Oct; 32(10):2041-2047. PubMed ID: 32277433
[TBL] [Abstract][Full Text] [Related]
5. A nomogram to assess small-intestinal neuroendocrine tumor ('carcinoid') survival.
Modlin IM; Gustafsson BI; Pavel M; Svejda B; Lawrence B; Kidd M
Neuroendocrinology; 2010; 92(3):143-57. PubMed ID: 20733279
[TBL] [Abstract][Full Text] [Related]
6. Health-related quality of life in well-differentiated metastatic gastroenteropancreatic neuroendocrine tumors.
Jiménez-Fonseca P; Carmona-Bayonas A; Martín-Pérez E; Crespo G; Serrano R; Llanos M; Villabona C; García-Carbonero R; Aller J; Capdevila J; Grande E;
Cancer Metastasis Rev; 2015 Sep; 34(3):381-400. PubMed ID: 26245646
[TBL] [Abstract][Full Text] [Related]
7. The impact of chronic orofacial pain on health-related quality of life.
Forssell H; Sipilä K; Teerijoki-Oksa T; Vartiainen P; Kautiainen H; Sintonen H; Kalso E
Scand J Pain; 2020 Apr; 20(2):329-338. PubMed ID: 31881002
[TBL] [Abstract][Full Text] [Related]
8. Survival and disease recurrence in patients operated for small intestinal neuroendocrine tumors at a referral hospital.
Folkestad O; Wasmuth HH; Mjønes P; Fougner R; Hauso Ø; Fossmark R
Surg Oncol; 2020 Dec; 35():336-343. PubMed ID: 32979699
[TBL] [Abstract][Full Text] [Related]
9. Health-related quality of life, anxiety, depression and impulsivity in patients with advanced gastroenteropancreatic neuroendocrine tumours.
Lewis AR; Wang X; Magdalani L; D'Arienzo P; Bashir C; Mansoor W; Hubner R; Valle JW; McNamara MG
World J Gastroenterol; 2018 Feb; 24(6):671-679. PubMed ID: 29456406
[TBL] [Abstract][Full Text] [Related]
10. Effects of Sandostatin LAR on gastrointestinal motility in patients with neuroendocrine tumors.
Gregersen T; Grønbæk H; Worsøe J; Schlageter V; Laurberg S; Krogh K
Scand J Gastroenterol; 2011 Jul; 46(7-8):895-902. PubMed ID: 21623673
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life in patients waiting for major joint replacement. A comparison between patients and population controls.
Hirvonen J; Blom M; Tuominen U; Seitsalo S; Lehto M; Paavolainen P; Hietaniemi K; Rissanen P; Sintonen H
Health Qual Life Outcomes; 2006 Jan; 4():3. PubMed ID: 16423293
[TBL] [Abstract][Full Text] [Related]
12. Impaired health-related quality of life in Addison's disease--impact of replacement therapy, comorbidities and socio-economic factors.
Kluger N; Matikainen N; Sintonen H; Ranki A; Roine RP; Schalin-Jäntti C
Clin Endocrinol (Oxf); 2014 Oct; 81(4):511-8. PubMed ID: 24801591
[TBL] [Abstract][Full Text] [Related]
13. Health-related quality of life in patients treated for nonfunctioning pituitary adenomas during the years 2000-2010.
Karppinen A; Ritvonen E; Roine R; Sintonen H; Vehkavaara S; Kivipelto L; Grossman AB; Niemelä M; Schalin-Jäntti C
Clin Endocrinol (Oxf); 2016 Apr; 84(4):532-9. PubMed ID: 26493182
[TBL] [Abstract][Full Text] [Related]
14. Management of Small Bowel Neuroendocrine Tumors.
Scott AT; Howe JR
Surg Oncol Clin N Am; 2020 Apr; 29(2):223-241. PubMed ID: 32151357
[TBL] [Abstract][Full Text] [Related]
15. Melatonin Immunoreactivity in Malignant Small Intestinal Neuroendocrine Tumours.
Söderquist F; Janson ET; Rasmusson AJ; Ali A; Stridsberg M; Cunningham JL
PLoS One; 2016; 11(10):e0164354. PubMed ID: 27736994
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life among prostate cancer patients: real-life situation at the beginning of treatment.
Bergius S; Torvinen S; Muhonen T; Roine RP; Sintonen H; Taari K
Scand J Urol; 2017 Feb; 51(1):13-19. PubMed ID: 27809631
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life is impaired in primary hyperparathyroidism and significantly improves after surgery: a prospective study using the 15D instrument.
Ryhänen EM; Heiskanen I; Sintonen H; Välimäki MJ; Roine RP; Schalin-Jäntti C
Endocr Connect; 2015 Sep; 4(3):179-86. PubMed ID: 26155796
[TBL] [Abstract][Full Text] [Related]
18. Health-Related Quality of Life for Long-Acting Octreotide versus Placebo in Patients with Metastatic Midgut Neuroendocrine Tumors in the Phase 3 PROMID Trial.
Rinke A; Neary MP; Eriksson J; Hunger M; Doan T; Karli D; Arnold R
Neuroendocrinology; 2019; 109(2):141-151. PubMed ID: 30852564
[TBL] [Abstract][Full Text] [Related]
19. Update on medical treatment of small intestinal neuroendocrine tumors.
Pusceddu S; Femia D; Lo Russo G; Ortolani S; Milione M; Maccauro M; Vernieri C; Prinzi N; Concas L; Leuzzi L; De Braud F; Buzzoni R
Expert Rev Anticancer Ther; 2016 Sep; 16(9):969-76. PubMed ID: 27353232
[TBL] [Abstract][Full Text] [Related]
20. Principal component analysis, hierarchical clustering, and decision tree assessment of plasma mRNA and hormone levels as an early detection strategy for small intestinal neuroendocrine (carcinoid) tumors.
Modlin IM; Gustafsson BI; Drozdov I; Nadler B; Pfragner R; Kidd M
Ann Surg Oncol; 2009 Feb; 16(2):487-98. PubMed ID: 19050963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
